Aditxt Inc (ADTX)
2.43
-0.10
(-3.95%)
USD |
NASDAQ |
Apr 26, 16:00
2.43
0.00 (0.00%)
After-Hours: 20:00
Aditxt Cash from Financing (TTM): 15.92M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 15.92M |
September 30, 2023 | 14.23M |
June 30, 2023 | 20.80M |
March 31, 2023 | 19.21M |
December 31, 2022 | 17.53M |
September 30, 2022 | 37.04M |
June 30, 2022 | 29.30M |
March 31, 2022 | 27.69M |
December 31, 2021 | 35.95M |
Date | Value |
---|---|
September 30, 2021 | 16.32M |
June 30, 2021 | 25.39M |
March 31, 2021 | 25.68M |
December 31, 2020 | 17.89M |
September 30, 2020 | 17.97M |
June 30, 2020 | 0.6062M |
March 31, 2020 | 0.485M |
December 31, 2019 | 0.3527M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.3527M
Minimum
Dec 2019
37.04M
Maximum
Sep 2022
18.96M
Average
17.97M
Median
Sep 2020
Cash from Financing (TTM) Benchmarks
Evofem Biosciences Inc | 4.776M |
Perspective Therapeutics Inc | 0.785M |
Electromed Inc | -0.128M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |